维普期刊资源整合服务平台（V6.5）

42篇 您的检索式：作者名="Judson PL"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	A phase Ⅱ evaluation of Temozolomide in patients with recurrent epithelial ovarian cancer显示文摘	Judson PL Harkness B Boente MP	2004	Gynecologic Oncology2004，93，3：	1
2	Overexpression of focal adhesion kinase,a protein tyrosion kinase,in ovarian carcinoma显示文摘	Judson PL	1999	Cancer1999，86，8：	1
3	A phaseⅡstudy ofallogeneic natural killer cell therapy to treat patients withrecurrent ovarian and breast cancer显示文摘	Geller MA Cooley S Judson PL	2011	Cytotherapy2011，13，1：	1
4	A phase II study of allogeneie natural killer cell therapy to treat patients with recurrent ovarian and breast cancer显示文摘	Geller MA Cooley S Judson PL	2011	Cytotherapy2011，13，1：	1
5	A prosepective ran- domized trial of thalidomide with topotecan compared with potitecan alone in women with recurrent epithelial ovarian carcinoma显示文摘	Donwns LS Judson PL Argenta PA	2008	Cancer2008，112，2：	1
6	Aprospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma显示文摘	Downs LS Jr Judson PL Argenla PA		0，，02：	1
7	Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma显示文摘	Judson PL	1999	Cancer1999，86，8：	1
8	A phase I study ofifosfamide,paclitaxe,and carboplatin in advanced and recurrent cervical cancer显示文摘	Downs Ls Jr Judson PL Argenta PA	2003	Gynecol Oncol2003，95，2：	1
9	Trends in the incidence of invasive and in situ vulvar carclnoma显示文摘	Judson PL Habermann EB Baxter NN	2006	Obstet & Gynecol2006，107，5：	1
10	A phase I1 study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer显示文摘	Argenta PA Thomas SG Judson PL	2009	Gynecol Oncol2009，113，2：	1
11	Position emission tomography and leiomyomas cliniopathologic analysis of 3 cases of PET scan-positive leiomyomas and literature review显示文摘	Chura JC Truskinovsky AM Judson PL		0，，01：	1
12	Trends in the incidence of invasive and in situ vulvar cancer显示文摘	Judson PL Habermann EB Baxter NN	2006	Obstet Gynecol2006，107，5：	1
13	A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma显示文摘	Downs LS Jr Judson PL Argenta PA	2008	Cancer2008，112，2：	1
14	Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines显示文摘	Judson PL Watson JM Gehrig PA	1999	Cancer Res1999，59，5：	1
15	A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer 显示文摘	Argenta PA Thomas SG Judson PL	2009	Gynecol 0ncol2009，113，2：	1
16	Learning about ovarian cancer at the time of diagnosis & Video versus usual care显示文摘	Geller MA Downs LS Judson PL	2010	Gyne- col Oncol2010，119，2：	1
17	A phase Ⅰ study of ifosfamide,paclitaxel;and carboplatin in advanced and recurrent cervical cancer显示文摘	Downs Ls Jr Judson PL Argenta PA	2003	Gynecol Oncol2003，95，2：	1
18	A phase II study of allogeneic natural killer cell therapy to treat patients with re?current ovarian and breast cancer显示文摘	Geller MA Cooley S Judson PL	2011	Cytotherapy2011，13，1：	1
19	A phase I study of ifosfamide,paclitaxel and carboplatin in advanced and recurrent cervical cancer显示文摘	Downs LS Judson PL Argenta PA	2004	Gynecol Oncol2004，95，2：	1
20	A prospective randomized trial of tha- lidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian careinoma 显示文摘	Downs LS Jr Judson PL	2008	Cancer2008，112，2：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示